Actavis
Actavis launches Ondansetron tablets in the US
Published in Surgery Litigation and Law Weekly, July 20th, 2007
Ondansetron hydrochloride tablets, the generic equivalent of GlaxoSmithkline's Zofran(R) tablets, will be available in 4 mg and 8 mg strengths. Ondansetron hydrochloride tablets are indicated for prevention of nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery.
Annual sales of Ondansetron hydrochloride tablets in the US were approximately US$746 million for the twelve months ending March 2007 according to IMS...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Missouri Academy of Physician Assistants
Physician Assistants Thank Gov. Blunt for Signing Supervision Bill - Acute Lymphoblastic Leukemia
Research on acute lymphoblastic leukemia in children reported by scientists at Dokkyo Medical University, Department of Pediatrics - Advanced Medical Optics, Inc.
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb - Alcoholism
New findings from Birmingham University, Department of Pathology describe advances in alcoholism - Allergies Therapy
Investigators at Birmingham Heartlands Hospital, Department of Respiratory Medicine target allergies therapy - Allergies Therapy
Recent studies from University of Torino add new data to allergies therapy - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
